Stock Track | METIS TECHBIO-P Soars 5.53% Intraday on Strategic Partnership Announcement with Sandstone Biotech

Stock Track
05/18

METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.

The surge appears to be driven by the company's announcement of a comprehensive strategic technology cooperation agreement with Sandstone Biotech, a firm specializing in tumor immunocellular therapy. The collaboration focuses on immune-targeted lipid nanoparticle (LNP) delivery technology, leveraging METIS TECHBIO-P's AI-powered NanoForge platform to advance next-generation in vivo immunotherapy products. This partnership is part of the company's OpenCGT initiative, which has now seen cumulative collaboration values exceed RMB 60 billion.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10